Cargando…

iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery

Induced pluripotent stem cells (iPSCs)-based two-dimensional (2D) protocols have offered invaluable insights into the pathophysiology of neurological diseases. However, these systems are unable to reproduce complex cytoarchitectural features, cell-cell and tissue-tissue interactions like their in vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costamagna, Gianluca, Andreoli, Luca, Corti, Stefania, Faravelli, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912470/ https://www.ncbi.nlm.nih.gov/pubmed/31739555 http://dx.doi.org/10.3390/cells8111438

Ejemplares similares

Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
por: Costamagna, Gianluca, et al.
Publicado: (2021)

Understanding the pathophysiology of NOMID arthropathy for drug discovery by iPSCs technology
por: Nakagawa, K, et al.
Publicado: (2015)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Naive-like ESRRB(+) iPSCs with the Capacity for Rapid Neural Differentiation
por: Kisa, Fumihiko, et al.
Publicado: (2017)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

iPSCs: A Preclinical Drug Research Tool for Neurological Disorders
por: Bonaventura, Gabriele, et al.
Publicado: (2021)

iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development
por: Faravelli, Irene, et al.
Publicado: (2014)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

Human neural progenitors derived from integration-free iPSCs for SCI therapy
por: Liu, Ying, et al.
Publicado: (2017)

Proteasome impairment in neural cells derived from HMSN-P patient iPSCs
por: Murakami, Nagahisa, et al.
Publicado: (2017)

Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models
por: Zhang, Ying, et al.
Publicado: (2020)

iPSCs-based generation of vascular cells: reprogramming approaches and applications
por: Klein, Diana
Publicado: (2017)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
por: Arnst, Nikita, et al.
Publicado: (2021)

Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs
por: Supakul, Sopak, et al.
Publicado: (2023)

Impact of regulatory variation across human iPSCs and differentiated cells
por: Banovich, Nicholas E., et al.
Publicado: (2018)

Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
por: Orzechowski, Marcin, et al.
Publicado: (2020)

Modelling DMD-associated cardiomyopathy in patient-derived iPSCs
Publicado: (2015)

The State of Play with iPSCs and Spinal Cord Injury Models
por: Hodgetts, Stuart I., et al.
Publicado: (2015)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
por: Menon, Siddharth, et al.
Publicado: (2016)

Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs
por: Mao, Jian, et al.
Publicado: (2016)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
por: Kim, Eunhye, et al.
Publicado: (2016)

Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_86n499s51u58hlb7f14rnc9o1u